Sarah Cannon Cancer Research Institute is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Sarah Cannon Cancer Research Institute has participated in 2 clinical trials.
Therapeutic areas: Non-Hodgkin's Lymphoma, Hodgkin's Disease, Myelodysplastic Syndromes.
Sponsors: Cytokinetics, Gemin X.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Cancer Research Institute has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Cancer Research Institute has 2 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma, Hodgkin's Disease, Myelodysplastic Syndromes.
Sarah Cannon Cancer Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.